Trials / Sponsors / Tempest Therapeutics
Tempest Therapeutics
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Pr Hepatocellular Carcinoma (HCC) | Phase 3 | 2025-12-01 |
| Completed | Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer | Phase 1 | 2020-05-06 |
| Completed | TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma | Phase 1 | 2019-03-20 |